StockNews.com lowered shares of OraSure Technologies (NASDAQ:OSUR – Free Report) from a buy rating to a hold rating in a report issued on Tuesday.
Separately, Evercore ISI cut their target price on OraSure Technologies from $7.00 to $6.50 and set an in-line rating on the stock in a research report on Thursday, April 4th. Three research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, OraSure Technologies has a consensus rating of Hold and a consensus target price of $6.38.
View Our Latest Stock Report on OSUR
OraSure Technologies Stock Performance
OraSure Technologies (NASDAQ:OSUR – Get Free Report) last released its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.22 EPS for the quarter, topping the consensus estimate of $0.13 by $0.09. The firm had revenue of $75.88 million for the quarter, compared to analyst estimates of $74.13 million. OraSure Technologies had a return on equity of 14.50% and a net margin of 13.23%. OraSure Technologies’s revenue for the quarter was down 38.3% on a year-over-year basis. During the same period in the previous year, the company posted $0.21 EPS. On average, analysts forecast that OraSure Technologies will post -0.11 earnings per share for the current fiscal year.
Institutional Investors Weigh In On OraSure Technologies
A number of institutional investors have recently made changes to their positions in OSUR. SG Americas Securities LLC increased its holdings in shares of OraSure Technologies by 235.1% in the 3rd quarter. SG Americas Securities LLC now owns 41,982 shares of the medical instruments supplier’s stock valued at $249,000 after acquiring an additional 29,452 shares during the last quarter. Simplicity Solutions LLC grew its stake in OraSure Technologies by 146.4% during the 3rd quarter. Simplicity Solutions LLC now owns 40,036 shares of the medical instruments supplier’s stock worth $237,000 after buying an additional 23,789 shares during the last quarter. Inspire Investing LLC bought a new position in OraSure Technologies during the 3rd quarter worth $670,000. Allspring Global Investments Holdings LLC grew its stake in OraSure Technologies by 421.5% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 384,439 shares of the medical instruments supplier’s stock worth $2,280,000 after buying an additional 310,715 shares during the last quarter. Finally, Panagora Asset Management Inc. grew its stake in OraSure Technologies by 22.4% during the 3rd quarter. Panagora Asset Management Inc. now owns 387,368 shares of the medical instruments supplier’s stock worth $2,297,000 after buying an additional 70,894 shares during the last quarter. 93.50% of the stock is currently owned by institutional investors.
About OraSure Technologies
OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
See Also
- Five stocks we like better than OraSure Technologies
- Retail Stocks Investing, Explained
- Hasbro’s Management Made All the Right Calls This Quarter
- Roth IRA Calculator: Calculate Your Potential Returns
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Invest in Insurance Companies: A Guide
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.